Detection and classification of different liver lesions: Comparison of Gd-EOB-DTPA-enhanced MRI versus multiphasic spiral CT in a clinical single centre investigation

European Journal of Radiology

Volumn 82, Issue 11, 2013, Pages 1860-1869

  Böttcher, Joachim ^a   Hansch, Andreas ^b   Pfeil, Alexander ^b   Schmidt, Peter ^b   Malich, Ansgar ^c   Schneeweiss, Albrecht ^b   Maurer, Martin H ^d   Streitparth, Florian ^d   Teichgräber, Ulf K ^b   Renz, Diane M ^d  

^a Institute of Diagnostic and Interventional Radiology   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

^c Suedharz Clinic Nordhausen   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Computed tomography Liver; Gadoxetic acid; Gd EOB DTPA; Magnetic resonance imaging; Sequence analysis

Indexed keywords

GADOXETIC ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER INJURY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; RADIOLOGIST; SENSITIVITY AND SPECIFICITY;

COMPUTED TOMOGRAPHY; GADOXETIC ACID; GD-EOB-DTPA; LIVER; MAGNETIC RESONANCE IMAGING; SEQUENCE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; GERMANY; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 84885185726     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2013.06.013     Document Type: Article

References (30)

1. G.S. Gazelle, S.N. Goldberg, L. Solbiati, and T. Livraghi Tumor ablation with radio-frequency energy Radiology 217 2000 633 646
2. D.A. Kooby, and W.R. Jarnagin Surgical management of hepatic malignancy Cancer Investigation 22 2004 283 303
3. M.J. Powerski, C. Scheurig-Münkler, J. Banzer, D. Schnapauff, B. Hamm, and B. Gebauer Clinical practice in radioembolization of hepatic malignancies: a survey among interventional centers in Europe European Journal of Radiology 81 2012 e804 e811
4. E.C. Jones, J.L. Chezmar, R.C. Nelson, and M.E. Bernardino The frequency and significance of small (less than or equal to 15 mm) hepatic lesions detected by CT American Journal of Roentgenology 158 1992 535 539
5. L.H. Schwartz, E.J. Gandras, S.M. Colangelo, M.C. Ercolani, and D.M. Panicek Prevalence and importance of small hepatic lesions found at CT in patients with cancer Radiology 210 1999 71 74
6. M.F. Meloni, A. Andreano, E. Franza, M. Passamonti, and S. Lazzaroni Contrast enhanced ultrasound: should it play a role in immediate evaluation of liver tumors following thermal ablation? European Journal of Radiology 81 2012 e897 e902
7. L. Martí-Bonmatí MR imaging characteristics of hepatic tumors European Radiology 7 1997 249 258
8. C. Atasoy, and S. Akyar Multidetector CT: contributions in liver imaging European Journal of Radiology 52 2004 2 17
9. R.N. Low Abdominal MRI advances in the detection of liver tumours and characterisation Lancet Oncology 8 2007 525 535
10. A. Furlan, D. Marin, and P. Cabassa Enhancement pattern of small hepatocellular carcinoma (HCC) at contrast-enhanced US (CEUS), MDCT, and MRI: Intermodality agreement and comparison of diagnostic sensitivity between 2005 and 2010 American Association for the Study of Liver Diseases (AASLD) guidelines European Journal of Radiology 81 2012 2099 2105
11. N.S. Holalkere, D.V. Sahani, M.A. Blake, E.F. Halpern, P.F. Hahn, and P.R. Mueller Characterization of small liver lesions: added role of MR after MDCT Journal of Computer Assisted Tomography 30 2006 591 596
12. K. Sofue, U. Tateishi, M. Tsurusaki, Y. Arai, N. Yamazaki, and K. Sugimura MR imaging of hepatic metastasis in patients with malignant melanoma: evaluation of suspected lesions screened at contrast-enhanced CT European Journal of Radiology 81 2012 714 718
13. M. Benndorf, J. Schelhorn, M. Dietzel, W.A. Kaiser, and P.A. Baltzer Diffusion weighted imaging of liver lesions suspect for metastases: apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration European Journal of Radiology 81 2012 e849 e853
14. R.C. Semelka, and T.K. Helmberger Contrast agents for MR imaging of the liver Radiology 218 2001 27 38
15. B. Hamm, T. Staks, and A. Mühler Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging Radiology 195 1995 785 792
16. P. Reimer, E.J. Rummeny, and K. Shamsi Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence Radiology 199 1996 177 183
17. H. Akai, S. Kiryu, and I. Matsuda Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: comparison with triple phase 64 detector row helical CT European Journal of Radiology 80 2011 310 315
18. J. Halavaara, J. Breuer, and C. Ayuso Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT - a multicenter trial Journal of Computer Assisted Tomography 30 2006 345 354
19. T. Ichikawa, K. Saito, and N. Yoshioka Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease Investigative Radiology 45 2010 133 141
20. R. Hammerstingl, A. Huppertz, and J. Breuer Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions European Radiology 18 2008 457 467
21. S.S. Raman, C. Leary, and D.A. Bluemke Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 3 clinical trial Journal of Computer Assisted Tomography 34 2010 163 172
22. D.A. Bluemke, D. Sahani, and M. Amendola Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study Radiology 237 2005 89 98
23. A. Huppertz, S. Haraida, and A. Kraus Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT - initial observations Radiology 234 2005 468 478
24. A. Huppertz, T. Balzer, and A. Blakeborough Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings Radiology 230 2004 266 275
25. C. Schwenke, and R. Busse Analysis of differences in proportions from clustered data with multiple measurements in diagnostic studies Methods of Information in Medicine 46 2007 548 552
26. F. Sardanelli, and G. Di Leo Biostastistics for radiologists 2009 Springer Milan, Berlin, Heidelberg, New York
27. J. Landis, and G. Koch The measurement of observer agreement for categorical data Biometrics 33 1977 159 174
28. T.J. Vogl, S. Kümmel, and R. Hammerstingl Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA Radiology 200 1996 59 67
29. G.C. Mueller, H.K. Hussain, R.C. Carlos, H.V. Nghiem, and I.R. Francis Effectiveness of MR imaging in characterizing small hepatic lesions: routine versus expert interpretation American Journal of Roentgenology 180 2003 673 680
30. H. Chandarana, and B. Taouli Diffusion and perfusion imaging of the liver European Journal of Radiology 76 2010 348 358